598 related articles for article (PubMed ID: 17027827)
21. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
Rodilla E; Pérez-Lahiguera F; Costa JA; González C; Miralles A; Moral D; Pascual JM
Med Clin (Barc); 2009 Jan; 132(1):1-6. PubMed ID: 19174057
[TBL] [Abstract][Full Text] [Related]
22. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
23. Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease.
Zapolski T; Waciński P; Kondracki B; Rychta E; Buraczyńska MJ; Wysokiński A
Kardiol Pol; 2011; 69(4):319-26. PubMed ID: 21523662
[TBL] [Abstract][Full Text] [Related]
24. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Onat A; Hergenç G; Can G; Küçükdurmaz Z
Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
[TBL] [Abstract][Full Text] [Related]
25. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects.
Kim BJ; Kim TY; Koh JM; Kim HK; Park JY; Lee KU; Shong YK; Kim WB
Clin Endocrinol (Oxf); 2009 Jan; 70(1):152-60. PubMed ID: 18494864
[TBL] [Abstract][Full Text] [Related]
26. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
[TBL] [Abstract][Full Text] [Related]
27. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
[TBL] [Abstract][Full Text] [Related]
28. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population.
García-Lorda P; Bulló M; Balanzà R; Salas-Salvadó J
Int J Obes (Lond); 2006 Mar; 30(3):468-74. PubMed ID: 16314875
[TBL] [Abstract][Full Text] [Related]
31. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference.
Onat A; Hergenç G; Yüksel H; Can G; Ayhan E; Kaya Z; Dursunoğlu D
Clin Nutr; 2009 Feb; 28(1):46-51. PubMed ID: 19010573
[TBL] [Abstract][Full Text] [Related]
32. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study.
Ioachimescu AG; Brennan DM; Hoar BM; Hazen SL; Hoogwerf BJ
Arthritis Rheum; 2008 Feb; 58(2):623-30. PubMed ID: 18240236
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.
Martínez MA; Puig JG; Mora M; Aragón R; O'Dogherty P; Antón JL; Sánchez-Villares T; Rubio JM; Rosado J; Torres R; Marcos J; Pallardo LF; Banegas JR;
Metabolism; 2008 Sep; 57(9):1232-40. PubMed ID: 18702949
[TBL] [Abstract][Full Text] [Related]
34. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
35. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Can G
Atherosclerosis; 2007 Mar; 191(1):182-90. PubMed ID: 16678831
[TBL] [Abstract][Full Text] [Related]
36. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
Hjortnaes J; Algra A; Olijhoek J; Huisman M; Jacobs J; van der Graaf Y; Visseren F
J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269
[TBL] [Abstract][Full Text] [Related]
37. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents.
Ford ES; Li C; Cook S; Choi HK
Circulation; 2007 May; 115(19):2526-32. PubMed ID: 17470699
[TBL] [Abstract][Full Text] [Related]
38. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
39. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
Lin JD; Chiou WK; Chang HY; Liu FH; Weng HF
Metabolism; 2007 Jun; 56(6):751-6. PubMed ID: 17512306
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
